Bafna Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE878I01022
  • NSEID: BAFNAPH
  • BSEID: 532989
INR
149.40
-3 (-1.97%)
BSENSE

Dec 05

BSE+NSE Vol: 28.3 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'20
Mar'19
Mar'18
Mar'17
Mar'16
Mar'15
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
2.37
23.66
23.66
18.66
18.66
18.66
Share Warrants & Outstandings
Total Reserve
-6.61
-4.60
14.27
20.01
39.10
53.12
Shareholder's Funds
51.11
19.06
37.93
42.67
57.75
71.78
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
2.54
22.99
23.25
39.01
35.17
11.64
Secured Loans
0.00
20.86
21.08
36.77
35.17
11.64
Unsecured Loans
2.54
2.13
2.17
2.24
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
6.18
5.11
2.92
3.82
4.00
Other Long Term Liabilities
0
0.63
12.95
12.79
0.92
0.39
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
3.02
29.80
41.31
54.72
39.91
16.03
Current Liabilities
Trade Payables
12.54
39.56
28.61
23.90
37.70
42.25
Other Current Liabilities
4.56
8.02
7.95
14.19
12.04
11.83
Short Term Borrowings
0.00
23.24
23.29
43.37
45.31
57.01
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
17.10
70.82
59.85
81.47
95.05
111.09
Total Liabilities
71.31
119.47
138.36
178.31
192.71
199.83
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
74.13
72.91
79.77
79.65
79.67
77.36
Less: Accumulated Depreciation
39.12
35.85
34.88
31.04
27.06
22.80
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
35.00
37.05
44.90
48.61
52.61
54.56
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.21
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
16.90
16.90
16.90
Long Term Loans & Advances
0.00
32.95
44.20
35.03
0.00
0.00
Other Non Current Assets
0.00
1.00
0.53
0.58
0.75
1.32
Total Non-Current Assets
35.22
71.00
89.62
101.12
70.22
72.74
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
11.41
9.28
10.67
16.74
16.38
16.12
Sundry Debtors
6.03
24.83
24.28
53.78
67.96
88.69
Cash and Bank
8.48
2.71
2.95
2.66
2.71
2.77
Other Current Assets
7.18
10.81
10.05
3.40
0.18
0.00
Short Term Loans and Advances
2.99
0.83
0.78
0.61
35.24
19.51
Total Current Assets
36.10
48.47
48.74
77.18
122.48
127.09
Net Current Assets (Including Current Investments)
19.00
-22.35
-11.11
-4.29
27.44
16.00
Total Current Assets Excluding Current Investments
36.10
48.47
48.74
77.18
122.48
127.09
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.72
1.28
Total Assets
71.31
119.47
138.36
178.31
192.71
199.83
Contingent Liabilities
0.03
0.03
0.00
0.29
1.64
11.56
Total Debt
3.02
46.23
46.54
82.38
80.48
68.65
Book Value per share (adjusted)
-17.93
8.06
16.03
20.73
30.96
38.47
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 15.62% vs 6.41% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 18.63% vs 31.97% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 30.33% vs 26.05% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is -9.64% vs 7.40% in Mar 2024

Compare Balance Sheet Results of Bafna Pharma.
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
2.37
11.50
-9.13
-79.39%
Share Warrants & Outstandings
Total Reserve
-6.61
52.96
-59.57
-112.48%
Shareholder's Funds
51.11
64.46
-13.35
-20.71%
Minority Interest
0.00
5.19
-5.19
-100.00%
Long-Term Borrowings
2.54
32.27
-29.73
-92.13%
Secured Loans
0.00
19.39
-19.39
-100.00%
Unsecured Loans
2.54
12.88
-10.34
-80.28%
Deferred Tax Assets / Liabilities
0.00
-1.94
1.94
100.00%
Other Long Term Liabilities
0.00
0.07
-0.07
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
3.02
30.40
-27.38
-90.07%
Current Liabilities
Trade Payables
12.54
14.79
-2.25
-15.21%
Other Current Liabilities
4.56
17.01
-12.45
-73.19%
Short Term Borrowings
0.00
21.76
-21.76
-100.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
17.10
53.55
-36.45
-68.07%
Total Liabilities
71.31
153.60
-82.29
-53.57%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
74.13
57.40
16.73
29.15%
Less: Accumulated Depreciation
39.12
13.53
25.59
189.14%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
35.00
43.88
-8.88
-20.24%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.21
1.56
-1.35
-86.54%
Intangible assets under development
0.00
0.04
-0.04
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
10.72
-10.72
-100.00%
Long Term Loans & Advances
0.00
1.43
-1.43
-100.00%
Other Non Current Assets
0.00
5.60
-5.60
-100.00%
Total Non-Current Assets
35.22
63.23
-28.01
-44.30%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
11.41
28.24
-16.83
-59.60%
Sundry Debtors
6.03
27.68
-21.65
-78.22%
Cash and Bank
8.48
2.46
6.02
244.72%
Other Current Assets
7.18
11.68
-4.50
-38.53%
Short Term Loans and Advances
2.99
20.30
-17.31
-85.27%
Total Current Assets
36.10
90.37
-54.27
-60.05%
Net Current Assets (Including Current Investments)
19.00
36.82
-17.82
-48.40%
Total Current Assets Excluding Current Investments
36.10
90.37
-54.27
-60.05%
Miscellaneous Expenses not written off
0.00
2.63
-2.63
-100.00%
Total Assets
71.31
153.60
-82.29
-53.57%
Contingent Liabilities
0.03
17.00
-16.97
-99.82%
Total Debt
3.02
54.03
-51.01
-94.41%
Book Value per share (adjusted)
-17.93
56.05
-73.98
-131.99%
Annual - Borrowings
Borrowings 28.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.62% vs 6.41% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.63% vs 31.97% in Mar 2024

Annual - Fixed Assets
Fixed Assets 66.09 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 30.33% vs 26.05% in Mar 2024

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 84.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -9.64% vs 7.40% in Mar 2024